M. J. Dooley
Research Subjects
Research Interests
M. J. Dooley has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
D. Rischin
Department of Medical Oncology , Peter MacCallum Cancer Centre , East Melbourne 4 Faculty of Medicine , University of Melbourne , Melbourne , Australia
1 shared publicationS. G. Poole
Department of Pharmacy , Alfred Health , Melbourne 2 Faculty of Pharmacy and Pharmaceutical Sciences , Monash University , Melbourne
1 shared publication
Latest Publications
- Open Access
- 7 August 2013
- Published by Elsevier in Annals of Oncology
- Vol. 24 (11) , 2746-2752
Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose
Oncology clinicians are now routinely provided with an estimated glomerular filtration rate on pathology reports whenever serum creatinine is requested. The utility of using this for the dose determination of renally excreted drugs compared with other existing methods is needed to inform practice. Renal function was determined by [Tc99m]DTPA clearance in adult patients presenting for chemotherapy. Renal function was calculated using the 4-variable Modification of Diet in Renal Disease (4v-MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), Cockcroft and Gault (CG), Wright and Martin formulae. Doses for renal excreted cytotoxic drugs, including carboplatin, were calculated. The concordance of the renal function estimates according to the CKD classification with measured Tc99mDPTA clearance in 455 adults (median age 64.0 years: range 17–87 years) for the 4v-MDRD, CKD-EPI, CG, Martin and Wright formulae was 47.7%, 56.3%, 46.2%, 56.5% and 60.2%, respectively. Concordance for chemotherapy dose for these formulae was 89.0%, 89.5%, 85.1%, 89.9% and 89.9%, respectively. Concordance for carboplatin dose specifically was 66.4%, 71.4%, 64.0%, 73.8% and 73.2%. All bedside formulae provide similar levels of concordance in dosage selection for the renal excreted chemotherapy drugs when compared with the use of a direct measure of renal function.
- 7 August 2013
- Published by Elsevier in Annals of Oncology
- Vol. 24 (11) , 2746-2752
Open AccessDosing of cytotoxic chemotherapy: impact of renal function estimates on dose
Oncology clinicians are now routinely provided with an estimated glomerular filtration rate on pathology reports whenever serum creatinine is requested. The utility of using this for the dose determination of renally excreted drugs compared with other existing methods is needed to inform practice. Renal function was determined by [Tc99m]DTPA clearance in adult patients presenting for chemotherapy. Renal function was calculated using the 4-variable Modification of Diet in Renal Disease (4v-MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), Cockcroft and Gault (CG), Wright and Martin formulae. Doses for renal excreted cytotoxic drugs, including carboplatin, were calculated. The concordance of the renal function estimates according to the CKD classification with measured Tc99mDPTA clearance in 455 adults (median age 64.0 years: range 17–87 years) for the 4v-MDRD, CKD-EPI, CG, Martin and Wright formulae was 47.7%, 56.3%, 46.2%, 56.5% and 60.2%, respectively. Concordance for chemotherapy dose for these formulae was 89.0%, 89.5%, 85.1%, 89.9% and 89.9%, respectively. Concordance for carboplatin dose specifically was 66.4%, 71.4%, 64.0%, 73.8% and 73.2%. All bedside formulae provide similar levels of concordance in dosage selection for the renal excreted chemotherapy drugs when compared with the use of a direct measure of renal function.